Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Incorporate a hardware wallet into your security plan, plus complementary practices to reduce exposure and strengthen protection.
19,310 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
A major energy partnership could reshape Chevron's cash flow and the stock's appeal before 2027. This guide breaks do...
Investors rush to cash in on AI gains even as energy costs, regulatory hurdles, and labor shifts raise the risk profi...
A practical, scenario-driven look at predicting where SpaceX headed by 2026 and how investors can approach this high-...
Long-term investors can grow wealth with dividend ETFs built long-term that blend reliable income with growth potenti...
A celebrity moment about mom-shaming becomes a real-world lesson in personal finance. Learn practical steps to safegu...
As 2027 nears, the latest social security cola forecasts hint at a bigger raise. But higher checks aren’t a guarantee...
Micron's stock recently fell nearly 29% in a month, but the move isn’t signaling weaker fundamentals. This guide expl...
Tensions around Yemen’s Houthis could disrupt a key oil route and set off a chain reaction in markets. This guide exp...
A mid-size fund reduced its TriMas stake by about $5 million after a strong run, but didn’t exit the position entirel...
Ready to make rental properties a real pathway to retirement? This guide outlines three actionable strategies for 202...
Lemonade's shares swung wildly in a single session, rising on an earnings beat and then tumbling as expectations cool...